Including important advances in COVID-19 research, including data on testing kits and pregnancy.
Third conference marked by Special Session assessing the COVID-19 responses of South Africa, UK, Australia, New Zealand, Brazil Senegal and Turkey
New data provides insights with potential real-world implications for people living with TB including a one-third reduction in treatment time. U.S. researchers say cost of not ending TB by 2030 will be US$3 trillion and over 28 million deaths
President Bill Clinton addresses delegates at the Opening Ceremony. New global survey of potential COVID-19 vaccine acceptance demonstrates widespread hesitancy across communities in Europe and the United States.
Official Opening Press Conference to launch new global survey of potential COVID-19 vaccine acceptance demonstrating widespread regional hesitancy
Complete conference scientific programme unveiled
As Patroness of the Japan Anti-Tuberculosis Association (JATA), HIH Crown Princess Akishino of Japan will also give a speech at the Presentation Ceremony of the Princess Chichibu Memorial TB Global Award during the Closing Ceremony on 24 October.
TB survivors Tamaryn Green (South Africa) and Divya Sojan (India) to address the Opening Ceremony. Symposia session to publish new data on immunology post-partum outcomes of pregnant women with SARS-CoV-2.
Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) and a member of the White House COVID-19 taskforce to deliver keynote address on COVID-19 science
Study co-authored by United Nations Special Envoy for Tuberculosis estimates global economic cost of not ending TB by 2030. Breaking news on COVID-19 science, promising trial results around a blood tuberculosis (TB) biomarker and new TB treatment breakthrough for children, among other conference scientific highlights as full programme unveiled.